,17 In agreement with these reports, ApcMin/+;Rbbp9-/- mice developed fewer and smaller tumors in the small intestine, which is the dominant location of tumor occurrence in the ApcMin/+ mouse model, with reduced proliferative activity compared with control mice (Figure 5A–C). Here, RBBP9 is linked to neoplasm.